
Reata Pharmaceuticals Investor Relations Material
Latest events

Q1 2023
Reata Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Reata Pharmaceuticals Inc
Access all reports
Reata Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of therapies for serious or life-threatening diseases. The company specializes in small-molecule therapeutics targeting molecular pathways involved in oxidative stress and inflammation. The company is headquartered in Plano, Texas, and its shares are listed on the NASDAQ.
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
RETA
Country
🇺🇸 United States